The clinical value of measuring PCT for the diagnosis, follow-up and antibiotic guidance of severe bacterial infections has been confirmed in a large number of clinical trials [14], [15], [16], leading to the commercialization of many immunoassays to be used on conventional laboratory instrumentation. The gene discussed is CALCA; the disease is bacterial infectious disease.